Cargando…

Vasoactive Intestinal Peptide Knockout (VIP KO) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductase

BACKGROUND: We earlier reported spontaneous features of asthma in Vasoactive Intestinal Peptide knockout mice (VIP KO): 1) peribronchiolar airway inflammation, with accumulation of lymphocytes and eosinophils, 2) pro-inflammatory cytokine production of IL-5, IL-6, with IFN-γ, and 3) airway hyper-res...

Descripción completa

Detalles Bibliográficos
Autores principales: Szema, Anthony M, Hamidi, Sayyed A, Koller, Antonius, Martin, Dwight W
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277465/
https://www.ncbi.nlm.nih.gov/pubmed/22103391
http://dx.doi.org/10.1186/1471-2172-12-66
_version_ 1782223493938544640
author Szema, Anthony M
Hamidi, Sayyed A
Koller, Antonius
Martin, Dwight W
author_facet Szema, Anthony M
Hamidi, Sayyed A
Koller, Antonius
Martin, Dwight W
author_sort Szema, Anthony M
collection PubMed
description BACKGROUND: We earlier reported spontaneous features of asthma in Vasoactive Intestinal Peptide knockout mice (VIP KO): 1) peribronchiolar airway inflammation, with accumulation of lymphocytes and eosinophils, 2) pro-inflammatory cytokine production of IL-5, IL-6, with IFN-γ, and 3) airway hyper-responsiveness to inhaled methacholine. In human asthma, a phenotype with sulfite sensitivity leads to airway inflammation and hyper-responsiveness to inhaled sulfites, and is associated with upregulation of anti-oxidant protein lung carbonyl reductase. For the present experiments, we examined the role of VIP in modulating anti-oxidant genes and their proteins, including lung carbonyl reductase. RESULTS: Four male VIP KO mice and four wild-type age- and gender matched mice had lungs examined for whole genome microarray and a proteomics approach using mass spectrometry. The proteomics analysis revealed that a novel variant of anti-oxidant protein lung carbonyl reductase (car3) was uniquely and markedly elevated in the VIP KO mice. RT-PCR indicated that carbonic anhydrase 3, which is an anti-oxidant protein, was elevated in the VIP KO mice. CONCLUSIONS: These data support the concept that VIP influences the endogenous oxidant/antioxidant balance. One potential implication is that VIP and its analogues may be used to treat inflammatory diseases, including asthma.
format Online
Article
Text
id pubmed-3277465
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32774652012-02-11 Vasoactive Intestinal Peptide Knockout (VIP KO) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductase Szema, Anthony M Hamidi, Sayyed A Koller, Antonius Martin, Dwight W BMC Immunol Research Article BACKGROUND: We earlier reported spontaneous features of asthma in Vasoactive Intestinal Peptide knockout mice (VIP KO): 1) peribronchiolar airway inflammation, with accumulation of lymphocytes and eosinophils, 2) pro-inflammatory cytokine production of IL-5, IL-6, with IFN-γ, and 3) airway hyper-responsiveness to inhaled methacholine. In human asthma, a phenotype with sulfite sensitivity leads to airway inflammation and hyper-responsiveness to inhaled sulfites, and is associated with upregulation of anti-oxidant protein lung carbonyl reductase. For the present experiments, we examined the role of VIP in modulating anti-oxidant genes and their proteins, including lung carbonyl reductase. RESULTS: Four male VIP KO mice and four wild-type age- and gender matched mice had lungs examined for whole genome microarray and a proteomics approach using mass spectrometry. The proteomics analysis revealed that a novel variant of anti-oxidant protein lung carbonyl reductase (car3) was uniquely and markedly elevated in the VIP KO mice. RT-PCR indicated that carbonic anhydrase 3, which is an anti-oxidant protein, was elevated in the VIP KO mice. CONCLUSIONS: These data support the concept that VIP influences the endogenous oxidant/antioxidant balance. One potential implication is that VIP and its analogues may be used to treat inflammatory diseases, including asthma. BioMed Central 2011-11-21 /pmc/articles/PMC3277465/ /pubmed/22103391 http://dx.doi.org/10.1186/1471-2172-12-66 Text en Copyright ©2011 Szema et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Szema, Anthony M
Hamidi, Sayyed A
Koller, Antonius
Martin, Dwight W
Vasoactive Intestinal Peptide Knockout (VIP KO) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductase
title Vasoactive Intestinal Peptide Knockout (VIP KO) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductase
title_full Vasoactive Intestinal Peptide Knockout (VIP KO) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductase
title_fullStr Vasoactive Intestinal Peptide Knockout (VIP KO) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductase
title_full_unstemmed Vasoactive Intestinal Peptide Knockout (VIP KO) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductase
title_short Vasoactive Intestinal Peptide Knockout (VIP KO) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductase
title_sort vasoactive intestinal peptide knockout (vip ko) mouse model of sulfite-sensitive asthma: up-regulation of novel lung carbonyl reductase
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3277465/
https://www.ncbi.nlm.nih.gov/pubmed/22103391
http://dx.doi.org/10.1186/1471-2172-12-66
work_keys_str_mv AT szemaanthonym vasoactiveintestinalpeptideknockoutvipkomousemodelofsulfitesensitiveasthmaupregulationofnovellungcarbonylreductase
AT hamidisayyeda vasoactiveintestinalpeptideknockoutvipkomousemodelofsulfitesensitiveasthmaupregulationofnovellungcarbonylreductase
AT kollerantonius vasoactiveintestinalpeptideknockoutvipkomousemodelofsulfitesensitiveasthmaupregulationofnovellungcarbonylreductase
AT martindwightw vasoactiveintestinalpeptideknockoutvipkomousemodelofsulfitesensitiveasthmaupregulationofnovellungcarbonylreductase